The Roche Stress Toy: For Anemic Court Battles

1 Comment

roche-stress-toy.jpgDepending on one’s view, this little stress ball either resembles a drop of blood or a teardrop. The drugmaker, you may recall, did shed a tear last month when a federal jury in Boston ruled that its Mircera anemia med infringed on patents for Amgen’s Aranesp and Epogen treatments. Roche intends to appeal the decision, but the delay will cost the drugmaker a year or more before Mircera is available. To cope, Severin Schwan, who succeeds Franz Humer as ceo in March, may need the stress balls Roche was handing out to docs. Of course, everyone loses a patent fight now and then. Perhaps Franz can direct the marketing team to sell these to lawyers and recoup some of the Mircera investment.

Jump to comments

Share

Comments

  1. [...] You can read the rest of this blog post by going to the original source, here [...]

Subscribe

RSS Feed

Comments feed for this post only.

Tags

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/